Department of Industry, Innovation, Science, Research and Tertiary Education Website Archive

The content on this page and other DIISR archive pages is provided for historical reference only. The material in the DIISR archive has been superseded, or served a purpose at a particular time. It may contain references to activities or policies that have no current application.

Content in the archive may link to web pages that have moved or no longer exist, or may refer to other documents that are no longer available. Links to external websites do not constitute an endorsement or a recommendation of material on those sites or of any products or services offered by, from or through those sites.

Skip to main content
Ministers' website for Innovation, Industry, Science and Research
Go Search
Ministers' website for Innovation, Industry, Science and Research

Senator Kim Carr's media releases

INVESTING IN INNOVATIVE COMPANIES 

07 Dec 2011
AusIndustry logo 

Up to $100 million will be invested in new, innovative companies as part of the Australian Government's Innovation Investment Fund (IIF).

The Gillard Labor Government will support private sector investors to help ensure that new business ideas that originate in Australian firms and research organisations compete in global markets.

Announcing the final tranche of IIF Round three, Senator Kim Carr said the $100 million will lead to $200 million of venture capital for early-stage investments. It offers a bridge to larger venture capital funds with the capacity to make significant longer-term investments.

"Through the IIF, the Australian Government aims to increase investment in growth companies and connect them with international markets," Senator Carr said.

"Venture capital has been shown to be an effective mechanism for commercialising innovative technologies into new products, services and processes.

"We not only want to create high-value jobs and products that will boost productivity, but also enhance our international reputation for innovation and quality research."

Senator Carr highlighted Sydney-based biotech manufacturer Pharmaxis as a successful technology company supported by the Australian Government's Innovation Investment Fund.

"Pharmaxis is a great example. It is expanding its advanced research and manufacturing facilities in Sydney with $10 million of new equipment to make its cystic fibrosis treatment and an anti-asthma drug," Senator Carr said.

Pharmaxis Chief Executive Officer Dr Alan Robertson said: "R&D works better when it can be coupled directly to manufacturing."

One of Pharmaxis' backers, GBS Venture Partners (GBS), acknowledges that IIF gave it its start in the venture capital industry. GBS Managing Director Dr Geoff Brooke said the company now manages more than $400 million for investors, including major Australian superannuation funds.

"I am seeking applications from venture capital fund managers experienced in developing high-growth Australian companies to become globally competitive enterprises," Senator Carr said.

Applications for IIF tranche four close on Monday 2 July 2012. Details on information seminars for applicants are available at www.ausindustry.gov.au/IIF or through the AusIndustry Hotline 13 28 46.

A printable version of the media release [PDF 58KB] is available.

 

 Related Links

 Media Contacts

RSS feeds RSS news feed
Sign up to receive RSS news feeds
Email Updates Email updates
Sign up to receive email alerts
Share/Save/Bookmark

back to topBack to top
  Department Websites
Associated Websites
Most Viewed
Site Information